Tenax Therapeutics (TENX) Short-term Investments (2016 - 2017)
Historic Short-term Investments for Tenax Therapeutics (TENX) over the last 3 years, with Q3 2017 value amounting to $6.8 million.
- Tenax Therapeutics' Short-term Investments rose 21.59% to $6.8 million in Q3 2017 from the same period last year, while for Sep 2017 it was $6.8 million, marking a year-over-year increase of 21.59%. This contributed to the annual value of $3.3 million for FY2016, which is N/A changed from last year.
- Tenax Therapeutics' Short-term Investments amounted to $6.8 million in Q3 2017, which was up 21.59% from $6.6 million recorded in Q2 2017.
- Over the past 5 years, Tenax Therapeutics' Short-term Investments peaked at $16.5 million during Q4 2015, and registered a low of $3.3 million during Q4 2016.
- For the 3-year period, Tenax Therapeutics' Short-term Investments averaged around $7.6 million, with its median value being $6.8 million (2016).
- Per our database at Business Quant, Tenax Therapeutics' Short-term Investments tumbled by 8012.76% in 2016 and then grew by 21.59% in 2017.
- Quarter analysis of 3 years shows Tenax Therapeutics' Short-term Investments stood at $16.5 million in 2015, then tumbled by 80.13% to $3.3 million in 2016, then skyrocketed by 106.13% to $6.8 million in 2017.
- Its Short-term Investments stands at $6.8 million for Q3 2017, versus $6.6 million for Q2 2017 and $5.5 million for Q1 2017.